SUPN announcements Supernus Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

Supernus Pharmaceuticals, Inc. Complete list of announcements declared & dividend announcements by Supernus Pharmaceuticals, Inc. SUPN

Supernus Pharmaceuticals, Inc. SUPN listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Supernus Pharmaceuticals, Inc. SUPN

Supernus Pharmaceuticals (SUPN) Lags Q4 Earnings Estimates
Supernus Pharmaceuticals (SUPN) came out with quarterly earnings of [CO].02 per share, missing the Zacks Consensus Estimate of [CO].41 per share. This compares to earnings of [CO].43 per share a year ago. These figures are adjusted for
Announcement as on 27 February 2024

Supernus Pharmaceuticals (SUPN) Lags Q4 Earnings Estimates
Supernus Pharmaceuticals (SUPN) came out with quarterly earnings of [CO].02 per share, missing the Zacks Consensus Estimate of [CO].41 per share. This compares to earnings of [CO].43 per share a year ago. These figures are adjusted for
Announcement as on 27 February 2024

Supernus Pharmaceuticals (SUPN) Reports Q3 Loss, Tops Revenue Estimates
Supernus Pharmaceuticals (SUPN) came out with a quarterly loss of [CO].29 per share versus the Zacks Consensus Estimate of [CO].13. This compares to earnings of [CO].03 per share a year ago. These figures are adjusted for non-recurring
Announcement as on 09 November 2023

Supernus Pharmaceuticals (SUPN) Reports Q3 Loss, Tops Revenue Estimates
Supernus Pharmaceuticals (SUPN) came out with a quarterly loss of [CO].29 per share versus the Zacks Consensus Estimate of [CO].13. This compares to earnings of [CO].03 per share a year ago. These figures are adjusted for non-recurring
Announcement as on 09 November 2023

Announcements by Supernus Pharmaceuticals, Inc. first page |

SUPN Supernus Pharmaceuticals, Inc. current price & indicator signals

Moving Averages for Supernus Pharmaceuticals, Inc.

  • 5Day Average: 37.18
  • 12Day Average: 36.59
  • 20Day Average: 36.45
  • 50Day Average: 35.84
  • 100Day Average: 34.43
  • 150Day Average: 32.3
  • 200Day Average: 31.82

SUPN Indicators & signals

Indicator MACD (12,26,9)

36.85, 36.39, 0.32
Indicator MACD is in positive zone

Indicator ADX (14)

34.78, 26.27, 12.71
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 47
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of SUPN Supernus Pharmaceuticals, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
08 Wed Jan 2025 38.06 36.76 to 38.31 1.68% 0.81 times
07 Tue Jan 2025 37.43 36.48 to 37.55 1.03% 0.68 times
06 Mon Jan 2025 37.05 36.80 to 38.33 0.35% 2.39 times
03 Fri Jan 2025 36.92 36.28 to 36.93 1.35% 0.62 times
02 Thu Jan 2025 36.43 36.10 to 36.90 0.75% 0.88 times
31 Tue Dec 2024 36.16 35.73 to 37.05 -2.03% 0.93 times
30 Mon Dec 2024 36.91 35.96 to 37.28 -0.73% 1.35 times
27 Fri Dec 2024 37.18 35.70 to 37.34 2.48% 1.64 times
26 Thu Dec 2024 36.28 35.37 to 36.29 1.91% 0.44 times
24 Tue Dec 2024 35.60 34.78 to 35.64 0.03% 0.34 times
23 Mon Dec 2024 35.59 34.81 to 35.66 0.45% 0.72 times
20 Fri Dec 2024 35.43 34.38 to 36.29 -0.95% 2.9 times

Videos related to: SUPN announcements Supernus Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

Videos related to: SUPN announcements Supernus Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

SUPN announcements Supernus Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

 

Back to top